Dublin, December 1, 2021/PRNewswire/-"Anesthesia Video Laryngoscope Market: Global Industry Trends, Share, Scale, Growth, Opportunities and Forecasts 2021-2026" report has been added to ResearchAndMarkets.com's products.
From 2015 to 2020, the global anesthesia video laryngoscope market has shown a moderate growth. Looking ahead, publishers expect the market to grow at a compound annual growth rate of around 6% during the period 2021-2026. Keeping in mind the uncertainty of COVID-19, we are constantly tracking and evaluating the direct and indirect impact of the pandemic on different end-use sectors. These insights are included in the report as major market contributors. Anesthesia video laryngoscope is an intubation device used to provide a corner view of the anterior larynx. It includes blades, batteries, cameras, and connected monitors to display magnified images of airway structures and facilitate endotracheal intubation (ETI). Unlike traditional direct laryngoscopy (DL), video laryngoscopy (VL) eliminates the requirement for practitioners to have a direct line of sight and helps them perform detailed inspections. Therefore, anesthesia video laryngoscopy is widely used in emergency or secondary care settings to manage complicated laryngoscopy cases. Because of their small size and portability, they are also used as teaching tools in medical institutions. Due to the increase in coronavirus disease (COVID-19) cases, the demand for anesthesia video laryngoscopes is also increasing to provide ETI for patients in non-operating room or non-operating room environments. It also keeps the health care professional's face away from the patient's respiratory tract, thereby minimizing the risk of transmission. These devices can also store video streams on SD memory cards. In addition, the rising prevalence of obesity and the improvement of healthcare infrastructure have also increased the adoption rate of anesthesia video laryngoscopes. In addition, leading players are focusing on introducing product variants that help pediatric care. This, combined with the increasing popularity of minimally invasive surgery (MIS), is expected to drive market growth in the coming years.
The report also analyzes the competitive landscape of the market. Some of the main players are Ambu A/S, ATMOS MedizinTechnik GmbH & Co. KG, BOMImed Inc., Clarus Medical LLC, Daiken Medical Co Ltd., KARL STORZ SE & Co. KG , Medtronic Plc, Olympus Corporation, Orlvision GmbH, Prosurg Inc., Teleflex Incorporated, Velosal Medical Incorporated, Verathon Inc. (Roper Technologies) and XION GmbH (Henke-Sass, Wolf GmbH). Key questions answered in this report:
So far, how has the global anesthesia video laryngoscope market performed, and how will it perform in the next few years?
What are the main regional markets?
What is the impact of COVID-19 on the global anesthesia video laryngoscope market?
What is the product-based market segmentation?
What is the market segmentation based on blade type?
What is the market segmentation based on the end user?
What are the various stages of the industry value chain?
What are the key drivers and challenges of the industry?
What is the structure of the global anesthesia video laryngoscope market and who are the main players?
How competitive is the industry?
Key topics covered: 1 Foreword 2 Scope and methodology 3 Executive summary 4 Introduction 4.1 Overview 4.2 Main industry trends 5 Global anesthesia video laryngoscope market 5.1 Market overview 5.2 Market performance 5.3 Impact of COVID-19 5.4 Market forecast 6 Market by product Segmentation 6.1 Rigid Laryngoscope 6.1.1 Market Trend 6.1.2 Market Forecast 6.2 Rhinal Flexible Laryngoscope 6.2.1 Market Trend 6.2.2 Market Forecast 7 Market Segmentation by Blade Type 7.1 Channel Blade Laryngoscope 7.1.1 Market Trend 7.1.2 Market Forecast Blade 7.2 Unguided Channel Blade 7.2.1 Market Trend 7.2.2 Market Forecast 8 End User Market Segmentation 8.1 Hospital 8.1.1 Market Trend 8.1.2 Market Forecast 8.2 Intensive Care Center 8.2.1 Market Trend 8.2.2 Market Forecast 8.3 Other 8.3.1 Market Trends 8.2 Market Forecast 9 Market Segmentation by Region 10 SWOT Analysis 11 Value Chain Analysis 12 Porter's Five Forces Analysis 13 Price Analysis 14 Competition Landscape 14.1 Market Structure 14.2 Key Plans 14.3 Introduction to the main participants 14.3.1 Ambu A/S 14.3.1.1 Company overview 14.3.1.2 Product portfolio 14.3.1.3 Finance 14.3.1.4 SWOT analysis 14.3.1 ATMOS MedizinTechnik GmbH & Co. KG.1.23. 13. Company overview Product portfolio 14.3.2 BOMImed Inc. 14.3.2.1 Company overview 14.3.2.2 Product portfolio 14.3.3 Clarus Medical LLC 14.3.3.1 Company overview 14.3.3.2 Product portfolio 14.3.4 Daiken Medical Co Ltd. 14.3.3.4.2.2 Product portfolio 14.3.4.3 Finance 14.3.5 KARL STORZ SE & Co. KG 14.3.5.1 Company overview 14.3.5.2 Product portfolio 14.3.5.3 Finance 14.3.5.4 SWOT analysis 14.3.6 Medtronic Plc.6.14o3 Product portfolio company overview 14.3.5.2 14.3.7 Olin Bath Company 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Finance 14.3.7.4 SWOT Analysis 14.3.8 Orlvision GmbH 14.3.8.1 Company Overview 14.3.8.2. Product Portfolio. 9sur.134.134 Inc. .9.1 Company Overview 14.3. 9.2 Product portfolio 14.3.10 Tele f France Co., Ltd. 14.3.10.1 Company Profile 14.3.10.2 Product Portfolio 14.3.10.3 Finance 14.3.10.4 SWOT Analysis 14..3.11 Velosal Pharmaceuticals Co., Ltd. 14.3.11.1 Company Profile 14.3.11.2 Product Portfolio 14.3.12 Verathon Company (Roper Technology) 14.3.12.1 Company overview 14.3.12.2 Product portfolio 14.3.12.3 SWOT analysis 14.3.13 XION GmbH 14.3.13.1 Company overview 14.3.13.2 Product portfolio 14.3.13.3 Finance
For more information about this report, please visit https://www.researchandmarkets.com/r/r0tir0
Research and Marketing Laura Wood, Senior Manager press@researchandmarkets.com US Eastern Time Office hours call +1-917-300-0470 US/Canada toll free number +1-800-526-8630 GMT Office hours call +353-1 -416 -8900 US Fax: 646-607-1907 Fax (Outside the US): +353-1-481-1716
View the original text: https://www.prnewswire.com/news-releases/worldwide-anesthesia-video-laryngoscope-industry-to-2026---featuring-clarus-medical-daiken-medical-and-prosurg- among-other-301435476.html
These growth stocks are not household names. However.
Buffett's right-hand man just sounded the bubble alarm. Maybe it's time to heed his warning.
These companies not only provide high-yield expenditures, but also have a good track record of increasing expenditures on a regular basis.
Pfizer agreed to acquire Arena Pharmaceuticals, a US biotechnology company, for approximately US$6.7 billion.
These three companies involve different risks, but in the long run, each company can enhance your investment portfolio.
Nvidia's (NASDAQ: NVDA) share price has risen 140% so far this year, which is on top of the staggering 750% increase in the past three years. Buying popular technology stocks like Nvidia can be tricky. On the one hand, in the long run, NVIDIA has obvious opportunities to increase revenue and expand profits. Before deciding to buy Nvidia at these high points, the following most important factors need to be considered.
Our appeal from Stifel that day believes that the Fed is working hard to create a bubble of the century. This is what happened before.
As far as the market is concerned, in the past 20 years, many major events have had a considerable impact on stock performance. The good news for shareholders is that the days when Amazon created higher revenue without profits are long gone.
The market is satisfied with the prospect of the Fed raising interest rates. Here are the headlines from Monday, December 13, 2021, and the content to watch in the market.
The Biden administration is working hard to promote electric vehicles (EV). From the US$7.5 billion allocated in the “Rebuild Better” bill to expand and increase the charging station network, to political pressure on automakers to commit to increased production, the goal is to convert 40% of car sales to electric by the end of the decade Automobiles, it is very obvious that under Biden's leadership, the government is willing to promote major changes in the automobile industry. For investors, this political environment makes
Despite the surprise in the latest earnings report, AMC Entertainment Holdings, Inc. (NYSE: AMC) failed to hit a new high because the new Omicron variant undoubtedly frightened investors. However, the stock went against the broader market and overcame the sell-off, while AMC continued to fall-under pressure from insider selling.
The U.S. Bureau of Labor Statistics recently updated the inflation rate for November 2021, stating that the average price has risen by 6.8% in the past 12 months-if you keep the score, this is the highest level since 1982. The three contributors at Fool.com believe that Applied Materials (NASDAQ: AMAT), IBM (NYSE: IBM) and Micron Technology (NASDAQ: MU) can easily Beyond inflation, it's worth watching now. Nicholas Rossolillo (Applied Materials): Supply chain issues continue to cause severe damage to certain industries. There are many excellent semiconductor stocks there, but for investors who want to have wider exposure to the entire industry, I like Applied Materials.
The market has become hostile to expensive growth stocks, which may be bad news for Cloudflare.
Yuan platform (NASDAQ: FB), formerly known as Facebook, has attracted a lot of attention recently, mainly due to the reason for the name change. The company emphasized that it will actively invest to become the leader of Metaverse. On the other hand, some investors worry that the meta-platform may allocate time and financial resources to projects with uncertain results. Meta Platforms' business benefits from its family of social media applications, including Facebook, Instagram and WhatsApp.
Don't let the market's apparent disinterest make you think that this reflects their value.
The company is adding 15 billion U.S. dollars to its stock repurchase program, bringing the total authorization to approximately 15.2 billion U.S. dollars.
Eli Lilly & Co. said on Monday that it had entered into a strategic partnership with Foghorn Therapeutics Inc. on a new oncology target using Foghorn's proprietary gene flow control platform, a move that increased Foghorn's stock price by 26% in pre-IPO trading. As part of the transaction, Eli Lilly will pay US$300 million in advance and make a US$80 million equity investment in Foghorn, priced at US$20 per share. Foghorn's stock price closed at $11.99 on Friday. "The carcinogenic mutation of BRG1 affects a large number of cancer patients
Provide a suitable compound time frame for the stock to allow it to survive market volatility and potentially double your initial investment. I believe that the three stocks that can double your funds during this period of time are The Trade Desk (NASDAQ: TTD), Mercado Libre (NASDAQ: MELI) and Snow (New York Securities) Exchange code: SNOW). Everyone operates in the field of technology and has strong growth prospects in the future. Trade Desk operates a demand-side advertising platform.
At Insider Monkey, we carefully study the applications of nearly 867 top investment companies every quarter, and we have now completed the process for the latest reporting period. The data we collect allows us to obtain a large amount of collective knowledge based on the portfolio holdings of these companies as of September 30. at this[…]
Moderna's first product also had a significant impact on revenue. Of course, Moderna has always been great. Moderna's latest earnings report made the market shudder. First, experts say that the coronavirus will persist after the pandemic.